Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Medicine
Volume 2013 (2013), Article ID 692980, 3 pages
http://dx.doi.org/10.1155/2013/692980
Case Report

Sclerosing Cholangitis in Behçet’s Disease

1Department of Gastroenterology, Sahloul Hospital, 4000 Sousse, Tunisia
2Department of Radiology, Sahloul, Sousse, Tunisia

Received 14 May 2013; Revised 13 August 2013; Accepted 11 September 2013

Academic Editor: Gianfranco D. Alpini

Copyright © 2013 Aida Ben Slama Trabelsi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. O. Chazouillères, “Cholangites sclérosantes. Encycl Méd Chir (Editions Scientifiques et Médicales Elsevier SAS, Paris, tous droits réservés),” Hépatologie, 7-015-A-70, p. 8, 2002.
  2. T. Sakane, M. Takeno, N. Suzuki, and G. Inaba, “Behçet's disease,” New England Journal of Medicine, vol. 341, no. 17, pp. 1284–1291, 1999. View at Publisher · View at Google Scholar · View at Scopus
  3. M. Hisaoka, J. Haratake, and T. Nakamura, “Small bile duct abnormalities and chronic intrahepatic cholestasis in Behcet's syndrome,” Hepato-Gastroenterology, vol. 41, no. 3, pp. 267–270, 1994. View at Google Scholar · View at Scopus
  4. S. Engler, C. Elsing, C. Flechtenmacher, L. Theilmann, W. Stremmel, and A. Stiehl, “Progressive sclerosing cholangitis after septic shock: a new variant of vanishing bile duct disorders,” Gut, vol. 52, no. 5, pp. 688–693, 2003. View at Publisher · View at Google Scholar · View at Scopus
  5. S. Al-Benna, J. Willert, H. U. Steinau, and L. Steinstraesser, “Secondary sclerosing cholangitis, following major burn injury,” Burns, vol. 36, no. 6, pp. e106–e110, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. R. Mohsine, M. C. Blanchet, Z. El Rassi, T. Ponchon, and O. Boillot, “Liver transplantation for secondary sclerosing cholangitis following biliary surgery,” Gastroenterologie Clinique et Biologique, vol. 28, no. 2, pp. 181–184, 2004. View at Google Scholar · View at Scopus
  7. C. P. Goritsas, M. Repanti, E. Papadaki, N. Lazarou, and A. P. Andonopoulos, “Intrahepatic bile duct injury and nodular regenerative hyperplasia of the liver in a patient with polyarteritis nodosa,” Journal of Hepatology, vol. 26, no. 3, pp. 727–730, 1997. View at Publisher · View at Google Scholar · View at Scopus
  8. P. Bélénotti, C. Guervilly, P. Grandval et al., “Ischemic cholangitis in intensive care unit: favourable outcome with ursodesoxycholic acid and fenofibrate,” La Revue de Médecine Interne, vol. 34, no. 2, pp. 110–113, 2012. View at Publisher · View at Google Scholar
  9. R. Chapman, J. Fevery, A. Kalloo et al., “Diagnosis and management of primary sclerosing cholangitis,” Hepatology, vol. 51, no. 2, pp. 660–678, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. A. Stiehl, G. Rudolph, P. Klöters-Plachky, P. Sauer, and S. Walker, “Development of dominant bile duct stenoses in patients with primary sclerosing cholangitis treated with ursodeoxycholic acid: outcome after endoscopic treatment,” Journal of Hepatology, vol. 36, no. 2, pp. 151–156, 2002. View at Publisher · View at Google Scholar · View at Scopus